These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 6209861)

  • 21. [Propafenon and propranolol in the management of cardiac extrasystoles (author's transl)].
    Beck OA; Ihle C; Hochrein H
    Dtsch Med Wochenschr; 1982 Apr; 107(15):579-83. PubMed ID: 6175494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Double-blind randomized placebo-controlled study of the effects of slow release and immediate release forms of propafenone in patients ventricular extrasystole symptoms].
    Mastropasqua F; Totaro P; Massari F; Pitzalis MV; Rizzon P
    Cardiologia; 1998 Jun; 43(6):617-23. PubMed ID: 9675961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Oral propafenone in the long-term treatment of chronic ventricular arrhythmia].
    Vázquez García A; Marcos Sánchez F; Górgolas Hernández-Mora P; Durán Pérez-Navarro A
    Rev Clin Esp; 1986 Jun; 179(2):101. PubMed ID: 3738054
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of chronic ventricular extrasystole by propafenone (600 mg/d) in 2 or 3 daily doses].
    Lardoux H; Valère PE; Djiane P; Maarek-Charbit M
    Ann Cardiol Angeiol (Paris); 1993 May; 42(5):281-8. PubMed ID: 7690219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antiarrhythmic efficacy of mexiletine, propafenone and flecainide in ventricular premature beats. A comparative study in patients after myocardial infarction (author's transl)].
    Klempt HW; Nayebagha A; Fabry E
    Z Kardiol; 1982 May; 71(5):340-9. PubMed ID: 6180562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical study of the effectiveness of mexitil in the treatment of patients with extrasystole in old and advanced age].
    Korkuschko OW; Butenko AG; Schatilo WB
    Z Gerontol; 1987; 20(3):149-53. PubMed ID: 2442897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Value of propafenon in the control of ventricular extrasystolic arrhythmia. Clinical, electrocardiographic and laboratory evaluation in prolonged use].
    Giannini SD; Zillioto EE; Campanari JC; Formicola A
    Arq Bras Cardiol; 1980 Dec; 35(6):525-8. PubMed ID: 6167246
    [No Abstract]   [Full Text] [Related]  

  • 28. [Comparative studies of tocainide and propafenone in the treatment of ventricular arrhythmias].
    Gebhardt A; Schmuderer R; Hilpert P
    Arzneimittelforschung; 1984; 34(3):303-6. PubMed ID: 6428425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative evaluation of mexiletine and propafenone by dynamic electrocardiography].
    Marzegalli M; Bernasconi M; Brambilla G; Micheletti T; Potenza S; Regalia F; Barbaresco L; Bossi M
    G Ital Cardiol; 1984 May; 14(5):352-6. PubMed ID: 6468816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical evaluation of new antiarrhythmic agents: experiences with propafenone.
    Furlanello F; Disertori M; Vergara G; Guarnerio M; Dal Forno P; Padrini R; Gobbato S; Ferrari M
    Int J Clin Pharmacol Res; 1983; 3(2):101-5. PubMed ID: 6679511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiarrhythmic effectiveness of propafenone compared to lorajmine in ventricular arrhythmias. Controlled clinical trial.
    Sanna G; Meoli P; Bianchini C; Rovelli F
    G Ital Cardiol; 1983; 13(3):145-51. PubMed ID: 6350090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Serum concentration and AV-conduction time in oral treatment with propafenone during a several-days period (author's transl)].
    Meyer-Estorf G; Keller K; Beck OA; Hochrein H
    Z Kardiol; 1980 Jun; 69(6):417-20. PubMed ID: 6160684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antiarrhythmic drugs in chronic ventricular extrasystole (author's transl)].
    Klein G; Wirtzfeld A; Schlegel J; Himmler C; Neiss A
    Dtsch Med Wochenschr; 1980 Feb; 105(6):189-94. PubMed ID: 6153310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Ventricular extrasystole. Which should be treated and how?].
    Lekieffre J; Libersa C; Kacet S; Caron J; Marchand X
    Ann Cardiol Angeiol (Paris); 1986 Apr; 35(4):199-203. PubMed ID: 2427001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Propafenon therapy of arrhythmias in infancy and childhood (author's transl)].
    Weber H; Eigster G; Wesselhoeft H
    Monatsschr Kinderheilkd; 1981 Jul; 129(7):410-3. PubMed ID: 6167855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The significance of spontaneous variability in ventricular extrasystole in the evaluation of the effectiveness of therapy of ventricular extrasystole].
    Daxner P; Snincák M; Kepic S; Puskár V; Prokop M
    Vnitr Lek; 1990 Sep; 36(9):840-6. PubMed ID: 1701280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Propafenon in ventricular arrhythmia caused by ischemic cardiopathy. Quantitative study using the Holter system].
    de Brito FS; Pereira MH; Castro I; Maia IG
    Arq Bras Cardiol; 1979 Oct; 33(4):303-10. PubMed ID: 94993
    [No Abstract]   [Full Text] [Related]  

  • 38. [Lorcainide in stable ventricular extrasystole. A double-blind study with 48-hour continuous ECG recording].
    Buss J; Stegaru B; Geiger S; Gores D; Heene DL
    Dtsch Med Wochenschr; 1984 Nov; 109(48):1829-32. PubMed ID: 6209080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The use of propafenon in the acute and chronic treatment of supraventricular and ventricular arrhythmias].
    Menozzi C; Lolli G; Gheller G; Monducci I; Vergoni W; Cattabiani ML; Manenti E; Casali G
    Clin Ter; 1983 Apr; 105(2):125-33. PubMed ID: 6345053
    [No Abstract]   [Full Text] [Related]  

  • 40. [Propafenone in refractory supraventricular arrhythmias].
    Palumbo E; Svetoni N; Casini M; Spargi T; Biagi G; Lanzetta T
    G Ital Cardiol; 1984 May; 14(5):381-2. PubMed ID: 6468822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.